{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:27:56Z","timestamp":1753892876371,"version":"3.41.2"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In multiple sclerosis (MS), depression represents one of the most frequent psychiatric comorbidities, significantly impacting patients\u2019 quality of life and disease progression. However, the diagnosis and management of depression in MS remain challenging due to overlapping symptoms and the lack of specific treatment guidelines. This Delphi study aims to achieve a shared consensus among Italian MS experts regarding the clinical manifestations, diagnosis, and treatment of depression in MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>An online Delphi survey with 35 questions covering the epidemiology, clinical features, diagnostic criteria, and treatment of depression in MS was anonymously administered to a panel of 51 expert neurologists across Italy. The consensus was based on a two-round Delphi process.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Consensus was reached on 100% of the statements. Positive consensus was achieved on 90.6% of the statements, while 9.4% reached negative consensus. Key findings include the strong link between depression and MS, with depressive symptoms often preceding MS onset. The panel agreed that the DSM-5 diagnostic criteria should be adapted to capture the specific mood disturbances seen in MS. Regarding treatment, antidepressants were widely prescribed, but concerns about their efficacy in the MS population remain. Non-pharmacological interventions, such as cognitive behavioral therapy (CBT), were considered essential components of comprehensive care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This Delphi study highlights the need for tailored diagnostic tools and integrated treatment approaches for managing depression in MS. Further studies are required to refine guidelines for the use of antidepressants and explore the role of disease-modifying therapies (DMTs) in treating depression in this population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1557335","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:10:37Z","timestamp":1751274637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatment"],"prefix":"10.3389","volume":"16","author":[{"given":"Antonio","family":"Bruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ettore","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Annovazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinella","family":"Clerico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girolama Alessandra","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Tomassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina Torri","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Totaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200154","article-title":"Clinical practice guidelines for the detection and treatment of depression in multiple sclerosis","volume":"13","author":"McIntosh","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2017.1322555","article-title":"Depression in multiple sclerosis","volume":"29","author":"Patten","year":"2017","journal-title":"Int Rev Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/brainsci11060751","article-title":"The effect of depression on health-related quality of life is mediated by fatigue in persons with multiple sclerosis","volume":"11","author":"Rodgers","year":"2021","journal-title":"Brain Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508099477","article-title":"The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated","volume":"15","author":"Marrie","year":"2009","journal-title":"Multiple Sclerosis J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.139","article-title":"The link between multiple sclerosis and depression","volume":"10","author":"Feinstein","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2015.10.004","article-title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","volume":"5","author":"Fiest","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10880-014-9409-0","article-title":"Routine depression screening in an MS clinic and its association with provider treatment recommendations and related treatment outcome","volume":"21","author":"Stepleman","year":"2014","journal-title":"J Clin Psychol Med Settings"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3182996400","article-title":"Duloxetine is effective in treating depression in multiple sclerosis patients","volume":"36","author":"Solaro","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-244X-14-5","article-title":"Cognitive behavioral therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis","volume":"14","author":"Hind","year":"2014","journal-title":"BMC Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181f4d80d","article-title":"MS quality of life, depression, and fatigue improve after mindfulness training","volume":"75","author":"Grossman","year":"2010","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004411","article-title":"Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis","volume":"89","author":"Rossi","year":"2017","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.11.022","article-title":"Dopaminergic dysfunction is associated with IL-1\u03b2-dependent mood alterations in experimental autoimmune encephalomyelitis","volume":"74","author":"Gentile","year":"2015","journal-title":"Neurobiol Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.expneurol.2012.07.010","article-title":"TNF-\u03b1-mediated anxiety in a mouse model of multiple sclerosis","volume":"237","author":"Haji","year":"2012","journal-title":"Exp Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pnpbp.2018.08.008","article-title":"Cortical thickness in major depressive disorder: A systematic review and meta-analysis","volume":"88","author":"Suh","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00169","article-title":"Inflammation-associated synaptic alterations as shared threads in depression and multiple sclerosis","volume":"14","author":"Bruno","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neubiorev.2015.01.006","article-title":"Localized connectivity in depression: A meta-analysis of resting state functional imaging studies","volume":"51","author":"Iwabuchi","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"103736","DOI":"10.1016\/j.msard.2022.103736","article-title":"Disentangling self-reported fatigue, depression, and cognitive impairment in people with multiple sclerosis","volume":"61","author":"Plow","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241260550","article-title":"Impact of multiple sclerosis comorbidities on quality of life and job activity","volume":"30","author":"Mallucci","year":"2024","journal-title":"Multiple Sclerosis J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101386","DOI":"10.1016\/j.msard.2019.101386","article-title":"Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability","volume":"36","author":"Ochoa-Morales","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bjc.2016.55.issue-4","article-title":"The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life","volume":"55","author":"Hayter","year":"2016","journal-title":"Br J Clin Psychol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.16050085","article-title":"Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort","volume":"29","author":"Ribbons","year":"2017","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4103\/aian.aian_434_24","article-title":"Impact of cognitive and psychological functions in relapsing\u2013remitting multiple sclerosis: A cross-sectional study","author":"Yadav","year":"2024","journal-title":"Ann Indian Acad Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160261","article-title":"Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: an Italian multi-center study using the beck depression inventory","volume":"11","author":"Solaro","year":"2016","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.693440","article-title":"Onset symptom clusters in multiple sclerosis: characteristics, comorbidities, and risk factors","volume":"12","author":"Ajdacic-Gross","year":"2021","journal-title":"Front Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1191\/1352458505ms1162oa","article-title":"The Goldman Consensus statement on depression in multiple sclerosis","volume":"11","author":"Schiffer","year":"2005","journal-title":"Multiple Sclerosis J"},{"key":"B28","first-page":"91","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions","volume":"24","author":"Ramasubbu","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"101842","DOI":"10.1016\/j.smrv.2023.101842","article-title":"The prevalence of insomnia in multiple sclerosis: A meta-analysis","volume":"72","author":"Zeng","year":"2023","journal-title":"Sleep Med Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509347150","article-title":"Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients","volume":"15","author":"Honarmand","year":"2009","journal-title":"Multiple Sclerosis J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2018-066","article-title":"Prevalence and correlates of body image dissatisfaction in patients with multiple sclerosis","volume":"21","author":"Stevens","year":"2019","journal-title":"Int J MS Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.msard.2022.103910","article-title":"Associations between diet quality and depression, anxiety, and fatigue in multiple sclerosis","volume":"63","author":"Saul","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"B33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41398-023-02555-7","article-title":"Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis","volume":"13","author":"Margoni","year":"2023","journal-title":"Transl Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acs113","article-title":"Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis","volume":"28","author":"Sundgren","year":"2013","journal-title":"Arch Clin Neuropsychol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23279095.2024.2403764","article-title":"Relationship between neuropsychiatric symptoms and cognition in multiple sclerosis: A systematic review","author":"Helminen","year":"2024","journal-title":"Appl Neuropsychol Adult"},{"key":"B36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.2017.24.issue-1","article-title":"Default mode network changes in multiple sclerosis: a link between depression and cognitive impairment","volume":"24","author":"Bonavita","year":"2017","journal-title":"Eur J Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.v36.12","article-title":"Hippocampal- DMN disconnectivity in MS is related to WM lesions and depression","volume":"36","author":"Rocca","year":"2015","journal-title":"Hum Brain Mapp"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1037\/a0035919","article-title":"Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis","volume":"59","author":"Amtmann","year":"2014","journal-title":"Rehabil Psychol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/ene.2016.23.issue-4","article-title":"Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis","volume":"23","author":"Sacco","year":"2016","journal-title":"Eur J Neurol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155431","article-title":"Screening for depression in the general population with the center for epidemiologic studies depression (CES-D): A systematic review with meta-analysis","volume":"11","author":"Vilagut","year":"2016","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.nbd.2017.07.019","article-title":"Interferon-\u03b3 causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum","volume":"108","author":"Mandolesi","year":"2017","journal-title":"Neurobiol Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209135","article-title":"Investigating the prevalence of comorbidity in multiple sclerosis clinical trial populations","volume":"102","author":"Salter","year":"2024","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211031128","article-title":"Risk of depression in multiple sclerosis across disease-modifying therapies","volume":"28","author":"Longinetti","year":"2022","journal-title":"Multiple Sclerosis J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/070674370204700708","article-title":"Treatment-seeking rates and associated mediating factors among individuals with depression","volume":"47","author":"Bristow","year":"2002","journal-title":"Can J Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507072384","article-title":"Treatment of depression in people who have multiple sclerosis","volume":"13","author":"Sollom","year":"2007","journal-title":"Multiple Sclerosis J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000013","article-title":"Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS","volume":"82","author":"Minden","year":"2014","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000095699","article-title":"Symptomatic treatment of multiple sclerosis","volume":"56","author":"Henze","year":"2006","journal-title":"Eur Neurol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/13854046.2012.668220","article-title":"Presentation and validation of the multiple sclerosis depression rating scale: A test specifically devised to investigate affective disorders in multiple sclerosis patients","volume":"26","author":"Quaranta","year":"2012","journal-title":"Clin Neuropsychol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/2055217315608864","article-title":"Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study","volume":"1","author":"Papeix","year":"2015","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2012-036","article-title":"Relationship between disease-modifying therapy and depression in multiple sclerosis","volume":"15","author":"Kirzinger","year":"2013","journal-title":"Int J MS Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8642-5","article-title":"Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing\u2013remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomized, multicenter study (the GOLDEN study)","volume":"264","author":"Comi","year":"2017","journal-title":"J Neurol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.02.047","article-title":"A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study","volume":"364","author":"Montanari","year":"2016","journal-title":"J Neurol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.09.008","article-title":"Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review","volume":"26","author":"Gasim","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.03.024","article-title":"Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial","volume":"365","author":"Hunter","year":"2016","journal-title":"J Neurol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-016-0682-8","article-title":"Interaction between interleukin-1\u03b2 and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis","volume":"13","author":"Gentile","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2396396","article-title":"Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review","volume":"23","author":"Solmi","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796024000520","article-title":"The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomized clinical trials with meta-analysis and Trial Sequential Analysis","volume":"33","author":"Kamp","year":"2024","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00345-024-05003-3","article-title":"Antidepressant nonadherence and sexual dysfunction among young adult males: the cross-sectional YAMAN study","volume":"42","author":"Rabinowitz","year":"2024","journal-title":"World J Urol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/andr.13770","article-title":"Effect of antidepressants on ejaculation dysfunction in patients with depression and anxiety: A systematic review and network meta-analysis","author":"Wang","year":"2024","journal-title":"Andrology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2174\/011570159X326862240909105845","article-title":"Disease-modifying symptomatic treatment (DMST): the potential role of vortioxetine in the treatment of depression in patients with multiple sclerosis","volume":"23","author":"Dolcetti","year":"2024","journal-title":"Curr Neuropharmacol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3182613dce","article-title":"Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis","volume":"35","author":"Di Rezze","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-023-07123-4","article-title":"The effect of duloxetine on female sexual functions in the treatment of stress incontinence","volume":"308","author":"Biyikoglu","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.139345","article-title":"Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study","volume":"79","author":"Mostert","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.18070164","article-title":"Neuroprotective benefits of antidepressants in multiple sclerosis: are we missing the mark","volume":"31","author":"Grech","year":"2019","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306829","article-title":"Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis","volume":"85","author":"Foley","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.10.004","article-title":"Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions","volume":"18","author":"Nathoo","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001038","article-title":"Agomelatine effectiveness, tolerability, and impact on anhedonia in major depression","volume":"39","author":"di Giannantonio","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2017.04.057","article-title":"Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials","volume":"218","author":"Ballard","year":"2017","journal-title":"J Affect Disord"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S296451","article-title":"Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder","volume":"17","author":"McIntyre","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00017","article-title":"The efficacy of vortioxetine on anhedonia in patients with major depressive disorder","volume":"10","author":"Cao","year":"2019","journal-title":"Front Psychiatry"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.10.012","article-title":"Open, uncontrolled, nonrandomized, 9-month, off-label use of bupropion to treat fatigue in a single patient with multiple sclerosis","volume":"32","author":"Siniscalchi","year":"2010","journal-title":"Clin Ther"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113514878","article-title":"Resolution of sleepiness and fatigue: A comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union","volume":"28","author":"Cooper","year":"2014","journal-title":"J Psychopharmacol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515613643","article-title":"Prevalence of neuropathic pain in early multiple sclerosis","volume":"22","author":"Heitmann","year":"2016","journal-title":"Multiple Sclerosis J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/papr.2014.14.issue-8","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis","volume":"14","author":"Vollmer","year":"2014","journal-title":"Pain Practice"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011091.pub2","article-title":"Venlafaxine for neuropathic pain in adults","volume":"2017","author":"Gallagher","year":"2015","journal-title":"Cochrane Database Systematic Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211034320","article-title":"Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update","volume":"11","author":"Adamo","year":"2021","journal-title":"Ther Adv Psychopharmacol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03780-z","article-title":"Disparity between perceived needs and service provision: a cross-sectional study of Italians with multiple sclerosis","volume":"40","author":"Ponzio","year":"2019","journal-title":"Neurological Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2014.09.014","article-title":"Non-invasive Brain Stimulation Therapy in Multiple Sclerosis: A Review of tDCS, rTMS and ECT Results","volume":"7","author":"Palm","year":"2014","journal-title":"Brain Stimul"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2017.04.006","article-title":"Neurophysiology of synaptic functioning in multiple sclerosis","volume":"128","author":"Stampanoni Bassi","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4088\/JCP.16cs10905","article-title":"Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression","volume":"79","author":"McClintock","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clinph.2016.10.087","article-title":"Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)","volume":"128","author":"Lefaucheur","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1177\/21501319241288029","article-title":"Burden of care, depression, and anxiety among family caregivers of people with dementia","volume":"15","author":"Abdelhalim","year":"2024","journal-title":"J Prim Care Community Health"},{"key":"B83","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13643-024-02641-x","article-title":"Effectiveness of interventions for informal caregivers of people with end-stage chronic illness: a systematic review","volume":"13","author":"McGuigan","year":"2024","journal-title":"Syst Rev"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1557335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:10:42Z","timestamp":1751274642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1557335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":83,"alternative-id":["10.3389\/fpsyt.2025.1557335"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1557335","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"article-number":"1557335"}}